Universitätsklinikum Tübingen


Standort der Organisation:
Tübingen, Deutschland

Publikationen in Kooperation mit FAU-Wissenschaftern

Go to first page Go to previous page 1 von 7 Go to next page Go to last page
Teramoto, Y., Keim, U., Gesierich, A., Schuler, G., Fiedler, E., Tueting, T.,... Garbe, C. (2018). Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. British Journal of Dermatology, 178(2), 443-451. https://dx.doi.org/10.1111/bjd.15803
Bohnert, B.N., Menacher, M., Janessa, A., Woern, M., Schork, A., Daiminger, S.,... Artunc, F. (2018). Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome. Kidney International, 93(1), 159-172. https://dx.doi.org/10.1016/j.kint.2017.07.023
Hecht, M., Meier, F., Zimmer, L., Polat, B., Loquai, C., Weishaupt, C.,... Heinzerling, L. (2018). Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients. British Journal of Cancer, 118(6), 785-792. https://dx.doi.org/10.1038/bjc.2017.489
Buettner, F., Winter, S., Rausch, S., Hennenlotter, J., Kruck, S., Stenzl, A.,... Schaeffeler, E. (2018). Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma. Bmc Medicine, 16(1). https://dx.doi.org/10.1186/s12916-018-1088-5
Saussele, S., Hehlmann, R., Fabarius, A., Jeromin, S., Proetel, U., Rinaldetti, S.,... Lauseker, M. (2018). Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV. Leukemia, 32(5), 1222-1228. https://dx.doi.org/10.1038/s41375-018-0055-7
Kremer, A., Bowlus, C.L., Neff, G.W., Aspinall, R., Galambos, M.R., Goel, A.,... Boudes, P. (2018). Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study. (pp. 1464A-1465A).
Kirchberger, M.C., Ugurel, S., Mangana, J., Heppt, M., Eigentler, T., Berking, C.,... Heinzerling, L. (2018). FV03 MEK Inhibitors improved the Survival of NRAS-mutated Melanoma Patients by using Checkpoint Inhibitors: Results of a retrospective, multicenter Analysis of 364 Patients. (pp. 4-4).
Knispel, S., Zimmer, L., Gutzmer, R., Heinzerling, L., Weishaupt, C., Pfoehler, C.,... Ugurel, S. (2018). Influence of previous Radiotherapy on the Success of an immune-oncologic Therapy in metastatic Melanoma - a retrospective multicenter Study of ADO. (pp. 28-29).
Kirchberger, M.C., Ugurel, S., Mangana, J., Heppt, M.V., Eigentler, T.K., Berking, C.,... Heinzerling, L. (2018). MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients. European journal of cancer, 98, 10-16. https://dx.doi.org/10.1016/j.ejca.2018.04.010
Schaeffeler, E., Büttner, F., Reustle, A., Klumpp, V., Winter, S., Rausch, S.,... Schwab, M. (2018). Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin. European Urology Focus. https://dx.doi.org/10.1016/j.euf.2018.01.016
Weis, J., Hoenig, K., Bergelt, C., Faller, H.H., Brechtel, A., Hornemann, B.,... Büttner-Teleaga, A. (2018). Psychosocial distress and utilization of professional psychological care in cancer patients: An observational study in National Comprehensive Cancer Centers (CCCs) in Germany. Psycho-Oncology, 27(12), 2847-2854. https://dx.doi.org/10.1002/pon.4901
Mathew, N.R., Baumgartner, F., Braun, L., O'Sullivan, D., Thomas, S., Waterhouse, M.,... Zeiser, R. (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature Medicine. https://dx.doi.org/10.1038/nm.4484
Carl, J., Thedinga, H., Zipfel, S., & Thiel, A. (2018). Stimulating Weight Stigma in Future Experimental Designs on Physical Activity – Development and Pilot Validation of a Video Instrument. Obesity facts, 11(3), 206-220. https://dx.doi.org/10.1159/000487889
Simon, B., Wiesinger, M., Marz, J., Wistuba-Hamprecht, K., Weide, B., Schuler-Thurner, B.,... Uslu, U. (2018). The Generation of CAR-transfected NKT Cells for the Immunotherapy of Melanoma. (pp. 8-8).
Alber, M., Kalscheuer, V.M., Marco, E., Sherr, E., Lesca, G., Till, M.,... Minassian, B.A. (2017). ARHGEF9 disease: Phenotype clarification and genotype-phenotype correlation. Neurology Genetics, 3(3). https://dx.doi.org/10.1212/NXG.0000000000000148
Ripperger, T., Bielack, S.S., Borkhardt, A., Brecht, I.B., Burkhardt, B., Calaminus, G.,... Kratz, C.P. (2017). Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. American Journal of Medical Genetics Part A, 173(4), 1017-1037. https://dx.doi.org/10.1002/ajmg.a.38142
Offenmüller, S., Leiter, U., Bernbeck, B., Garbe, C., Eigentler, T., Borkhardt, A.,... Brecht, I. (2017). Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP). Klinische Padiatrie, 229(6), 322-328. https://dx.doi.org/10.1055/s-0043-118662
Hassel, J.C., Heinzerling, L., Aberle, J., Baehr, O., Eigentler, T.K., Grimm, M.-O.,... Gutzmer, R. (2017). Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions. Cancer Treatment Reviews, 57, 36-49. https://dx.doi.org/10.1016/j.ctrv.2017.05.003
Krug, D., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R.,... Sauer, R. (2017). Current controversies in radiotherapy for breast cancer. Radiation Oncology, 12(1). https://dx.doi.org/10.1186/s13014-017-0766-3

Zuletzt aktualisiert 2016-02-11 um 07:23